Frontiers in Transplantation Clinical Excellence through Innovation - 2022
Life Sciences & Medicine
Continuing Professional Development (CPD)
Not for credit
Available course dates:
To be confirmed
The Tenth Edition of the King's course Frontiers in Transplantation: Clinical Excellence through Innovation will run on 29 and 30 September 2022 as a virtual event. As in previous years, the course will focus on the innovative and unique aspects of the clinical science in transplantation that are taking place within King's. The emphasis this year will be on problems facing a transplant in sensitised individuals with HLA antibodies, mechanisms of AMR, novel strategies to prevent AMR by targeting complement or coagulation systems, mechanisms of immunological tolerance and novel ways to induce it and current and next generation Treg therapies.
What does this course cover?
The course will cover the following themes:
- Preventing I/R injury
- Antibody-Mediated Rejection and innovative treatments
- Chronic Rejection Trials
- State of the art in Regulatory T cell therapy for humans
What will I achieve?
At the end of the two-day course, attendees will have gained insight into:
- Targeted inhibition of complement and coagulation systems and the impact of these on I/R injury and AMR
- The complexity of chronic rejection
- Mechanisms of immunological tolerance, with emphasis on Regulatory T cells (Tregs)
- The current and future use of Treg therapy in the clinic
- CPD accreditation for this programme is in progress
Who will I learn with?
Professor of Human Transplant Immunology
Professor of Transplant Inflammation and Repair
Director, MRC Centre for Transplantation
Consultant and Senior Lecturer in Immunology
Consultant Transplant Surgeon
Translational Research Coordinator - Department of Immunobiology School of Immunology & Microbiological Sciences MRC Centre for Transplantation
Professor of Immune Regulation and Immunotherapy
MRC Clinical Research Training Fellow
Senior Lecturer at UEL, Visiting lecturer at KCL
Consultant Nephrologist and Clinical Lead for Nephrology at Guy’s Hospital
Chief Business Officer at Quell Therapeutics
Who is this for?
Anyone interested in this field of study
What is the teaching schedule?
Please find the teaching schedule below.